Drugmakers Must Report Clinical Trial Results Once Kept Secret

  • NIH rule requires disclosure even if FDA didn’t approve drug
  • Researchers risk losing NIH funding if they don’t comply

Pharmaceutical companies will no longer be able to keep confidential their clinical trial results for experimental drugs that aren’t approved for patient use.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.